Tirzepatide, the novel medication, is creating considerable excitement within the medical community. It functions differently from traditional diabetes medications, targeting multiple receptors involved in blood regulation and satiety. Initial research have demonstrated remarkable efficacy in controlling blood glucose in individuals with adult-onse